Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Major Depressive Disorder Market Expected to Grow Between 2025 And 2029?
There has been a stable expansion in the market size for major depressive disorder over the recent years. An increase from $6.12 billion in 2024 to $6.26 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 2.3%. This increase during the historic phase can be credited to advancements in pharmaceuticals, awareness about mental health, psychological therapies, and initiatives in public health.
The major depressive disorder market size is expected to see steady growth in the next few years. It will grow to $7.14 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to precision medicine, telepsychiatry and teletherapy, novel treatment modalities, global expansion of mental health services. Major trends in the forecast period include early intervention, peer support and online communities, holistic approaches, resilience and coping strategies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13042&type=smp
Which Primay Drivers Are Accelerating Growth in the Major Depressive Disorder Market?
The escalation in instances of substance misuse and alcohol addiction is anticipated to drive the expansion of the major depressive disorder market. Substance and alcohol addiction reference harmful and excessive usage patterns of various substances, including alcohol, leading to detrimental physical, psychological and social results. Major depressive disorder often occurs alongside this, and the coexistence of the two can cause a significant escalation in the risk of physical and mental damage. For example, a survey issued in July 2024 by the Substance Abuse and Mental Health Services Administration, a department of health and human services in the US, revealed that 3.1% of individuals (equivalent to 8.9 million) abused opioids in 2023. Moreover, 21.8% of people 12 years or older used marijuana, making it the most frequently misused illegal drug. Furthermore, in the previous month, 9.4% of those aged 12 or older had used nicotine vapes, rising from 8.3% in 2022. Hence, the escalation in the frequency of substance misuse and alcohol addiction is fueling the expansion of the major depressive disorder market.
Which Primary Segments of the Major Depressive Disorder Market Are Driving Growth and Industry Transformations?
The major depressive disordermarket covered in this report is segmented –
1) By Treatment: Psychotherapy; Medications; Electroconvulsive Therapy (ECT); Transcranial Magnetic Stimulation (TMS); Other Treatments
2) By Diagnosis: Physical Examinations; Laboratory Tests; Psychiatric Evaluations; Diagnostic And Statistical Manual of Mental Disorders (DSM-5); Other Diagnosis
3) By End-User: Clinics; Hospitals; Other End-Users
Subsegments:
1) By Psychotherapy: Cognitive Behavioral Therapy (CBT); Interpersonal Therapy (IPT); Dialectical Behavior Therapy (DBT); Psychodynamic Therapy
2) By Medications: Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs); Tricyclic Antidepressants (TCAs); Monoamine Oxidase Inhibitors (MAOIs); Atypical Antidepressants
3) Electroconvulsive Therapy (ECT): Unilateral ECT; Bilateral ECT; Modified ECT
4) Transcranial Magnetic Stimulation (TMS): Repetitive Transcranial Magnetic Stimulation (rTMS); Deep Transcranial Magnetic Stimulation (dTMS); Theta Burst Stimulation (TBS); Navigated Brain Stimulation (nTMS)
5) Other: Cognitive Behavioral Therapy (CBT); Psychodynamic Therapy; Interpersonal Therapy (IPT); Vagus Nerve Stimulation (VNS); Ketamine Therapy; Bright Light Therapy; Psychedelic-Assisted Therapy; Medication (Antidepressants)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13042&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Major Depressive Disorder Market?# Market?
North America was the largest region in the major depressive disorder market in 2024. The regions covered in major depressive disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Technological Trends Are Reshaping the Major Depressive Disorder Industry Dynamics?
The focus of leading firms in the major depressive disorder market is to gain an edge over competitors by creating and receiving approval for innovative products. As the demand for safer and more effective treatments rises, there has been an increase in drug approvals for the treatment of major depressive disorders, including VRAYLAR (cariprazine). In December 2022, the US-based pharmaceutical company, AbbVie Inc., obtained approval from the Food and Drug Administration (FDA) to use VRAYLAR (cariprazine) as a supplemental therapy to antidepressants for adults suffering from major depressive disorder (MDD). Designed as an unconventional antipsychotic medication, VRAYLAR, which adjusts dopamine and serotonin concentrations in the brain, became the first of its kind approved for additional treatment for major depressive disorder. Moreover, VRAYLAR comes in a capsule that is taken once a day.
View the full report here:
https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report
What Parameters Are Used to Define the Major Depressive Disorder Market?
Major depressive disorder refers to a mood disorder or depression that causes a persistent feeling of sadness and loss of interest, which can interfere with daily activities such as sleeping, eating, or working. It goes beyond normal fluctuations in mood and can significantly impact a person’s thoughts, feelings, behavior and physical well-being. The treatment for major depressive disorder involves several medical interventions that support the emotional well-being of an individual.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13042
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model